M Pharmaceutical Agrees to Acquire Assets from Chelatexx
Thursday, April 07, 2016
M Pharmaceutical Inc Signs definitive agreement to acquire reformulated orlistat for weight loss from Chelatexx LLC.
Says addition of C-103 provides a novel weight loss pharmaceutical product to M Pharma pipeline.
Entered into a definitive agreement to acquire assets from Chelatexx LLC related to a reformulated version of orlistat.
Company also announced it was undertaking a non-brokered private placement of up to $700,000.
Source : reuters.com
